AlphAIAlphAI — Financial news for AI agents
theglobeandmail.comAUG 202 min read$WT

Analysts Offer Insights on Financial Companies: WisdomTree (WT), Cypherpunk Technologies (CYPH) and FS KKR Capital (FSK)

Analysts updated ratings for WisdomTree (WT), Cypherpunk Technologies (CYPH), and FS KKR Capital (FSK). WT received a Buy rating with a $26 target (current: $23.39). CYPH got a Buy rating with a $1.60 target (current: $0.81). FSK was rated Hold with an $11 target (current: $12.00).

Original reporting
theglobeandmail.com
Published Aug 20, 2026, 1:40 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 21, 2026, 3:01 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Analysts Offer Insights on Financial Companies: WisdomTree (WT), Cypherpunk Technologies (CYPH) and FS KKR Capital (FSK) — source image
Source · theglobeandmail.com
Decision brief

The 30-second read

$WTBullishLow
01

Why it matters

Ratings provide modest guidance but lack new material events.

02

Market read

Rating reiterations may cause modest price adjustments but no major market shift.

03

What to watch

Potential liquidity constraints for small‑cap CYPH not addressed.

Relevance 4/10Novelty 3/10Timing: today

Background

Analyst rating updates for three financial‑sector stocks.

Company-level read

Ticker impact

$WTBullishMedium confidence
Context

Analyst reiterated Buy rating with $26 target; price at $23.39.

Expected impact

Small upside of ~10% if target is reached.

Evidence & confidence

Buy rating and higher target suggest limited upside.

$CYPHBullishMedium confidence
Context

Analyst reiterated Buy rating with $1.60 target; price at $0.81.

Expected impact

Potential ~100% gain if target is met.

Evidence & confidence

Target is double current price, indicating strong upside.

$FSKBearishMedium confidence
Context

Analyst maintained Hold rating with $11 target; price at $12.

Expected impact

Possible modest decline toward $11.

Evidence & confidence

Hold rating and target below current price suggest limited upside.

Market effects

Sector

Analyst upgrades may slightly lift sentiment in the financial sector.

Regional

Primarily U.S. market focus; limited regional effect.

Global

Minimal global impact beyond niche investors.

Counterpoint

What could challenge this read

Ratings may be overly optimistic given recent market volatility.

Key entities

  • Research Firm
    Northland Securities

    Provided Buy rating for WisdomTree.

  • Research Firm
    Cantor Fitzgerald

    Provided Buy rating for Cypherpunk Technologies.

  • Research Firm
    J.P. Morgan

    Maintained Hold rating for FS KKR Capital.

Read at source← All news

Related articles

OCT 6
$ZEC-USDMed

The Winklevoss Twins Plan to Invest $100 Million in the Coin That Outperformed Bitcoin

The Winklevoss twins' investment fund plans to invest up to $100 million in a Zcash (ZEC) ETF, which would trade on Nasdaq as WINK. The fund, advised by Cypherpunk Technologies (CYPH), aims to charge a 0.25% fee. Gemini Trust Company, part of the twins' Gemini exchange group, will securely store the coins. The move could benefit Gemini (GEMI), which has seen declining revenue and losses. The ETF's approval and actual investment remain uncertain.

247wallst.com3 min
OCT 2
$WTMed

WisdomTree (WT) Stock Is Up, What You Need To Know

WisdomTree (WT) stock rose 2.9% after Goldman Sachs increased its price target to $21.30, citing improved earnings and industry outlook. Shares later settled at $24.40, up 1.5% from the previous close. WT has seen volatility, with 11 moves over 5% in the past year. The stock is up 95% YTD, near its 52-week high of $25.04.

financialcontent.com2 min
OCT 2
$WTMed

WT Maintained by Craig-Hallum -- Price Target Raised to $29.00

Craig-Hallum raised its price target for WisdomTree (WT) to $29.00 from $24.00, maintaining a 'Buy' rating. The stock is currently priced at $24.73, which GuruFocus deems 40.1% overvalued. WT has a GF Score™ of 82/100, showing strong performance but concerns over valuation. Insiders have sold $736,800 in shares recently, with no purchases.

gurufocus.com2 min
OCT 2
$WTMed

WT Maintained by Goldman Sachs -- Price Target Raised to $21.30

Goldman Sachs maintained a Neutral rating on WisdomTree (WT) but raised its price target to $21.30 from $18.30. GuruFocus values WT at $17.65, suggesting a 41% overvaluation. The company has a GF Score of 82/100, with strong profitability and growth but low valuation metrics. Insiders have sold $736,800 worth of shares in the last three months.

gurufocus.com2 min
SEP 25
$WTMed

Should You Buy WisdomTree (WT) Stock After Its Latest Crypto Move?

WisdomTree (WT) reported record AUM of $162.9B in Q2 2026, up 30% YoY, with revenue at $177.2M and 40.5% operating margin. The company partnered with MoonPay to integrate its tokenized fund WTGXX, accessing 35M accounts. Despite GAAP losses from debt repurchases, management highlights long-term growth potential in digital assets. WT trades at a forward P/E of 17.30.

insidermonkey.com2 min
SEP 12
$FSKMedAI 9/10

FSK 8-K Filings - FS KKR Capital Corp. SEC 8-K

FS KKR Capital Corp. (FSK) reported Q2 2026 net investment income of $122M ($0.44/share), a net loss of $34M ($0.13/share), and NAV of $18.30/share. The company raised $150M via preferred stock and completed a $900M note issuance. Shareholders approved a share issuance proposal and elected four directors. FSK also announced a share repurchase program and a 50% fee waiver by its adviser.

stocktitan.net2 min